195 related articles for article (PubMed ID: 35838212)
1. Withdrawn: A Review of Current Evidence from Cardiovascular Manifestations and Outcomes in Patients with COVID-19.
Saberianpour S; Aleebrahim-Dehkordi E; Mazaheri E; Hasanpour-Dehkordi A
Curr Pharm Des; 2022 Jul; ():. PubMed ID: 35838212
[TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Covid-19 Study, Pathology and Therapeutics.
Lu DY
Infect Disord Drug Targets; 2022 Feb; ():. PubMed ID: 35168512
[TBL] [Abstract][Full Text] [Related]
3. Withdrawn: Biomarkers in Disease Diagnosis and the Role of LC-MS and NMR: A Review.
Ashaq I; Ahmad Sheikh A; Beri N; Mittal S; Javed Naim M; Alam O; Bawa S
Curr Pharm Des; 2022 Apr; ():. PubMed ID: 35410591
[TBL] [Abstract][Full Text] [Related]
4. WITHDRAWN: Pharmaceutical Nanoemulsion System: A Strategy to Enhance the Bioavailability of Drugs.
Kumar S; Waliyan P; Pahwa R; Ali J; Baboota S; Sharma S; Hyder Pottoo F
Curr Drug Metab; 2022 Jun; ():. PubMed ID: 35786182
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Cannabis Sativa In Phytotherapy : Reappraisal Of Therapeutic Potential And Regulatory Aspects.
Gupta P; Singh A; Shafi S; Ralli T; Pottoo FH; Kohli K
Curr Pharm Biotechnol; 2022 Oct; ():. PubMed ID: 36281862
[TBL] [Abstract][Full Text] [Related]
6. WITHDRAWN: Original Antigenic Sin in COVID-19: Hoskins Effect and Vaccine.
Khan M; Manzoor S; Ullah N; Khan D
Infect Disord Drug Targets; 2022 Mar; ():. PubMed ID: 35301955
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal Notice: Morphology of Coronary Arteries in Relation to Ischemic Heart Disease.
Leone A
Curr Pharm Des; 2021 Jan; ():. PubMed ID: 33463453
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal Notice: Atrial Fibrillation and Hypertension: “Quo Vadis”.
Walker M; Patel P; Kwon O; Koene RJ; Duprez DA; Kwon Y
Curr Hypertens Rev; 2019 May; ():. PubMed ID: 31057122
[TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Current Synopsis on siRNA Therapeutics as a Novel Anti-Cancer and Antiviral Strategy: Progress and Challenges.
Sharma S; Gautam RK; Kanugo A; Mishra DK; Kamal MA
Curr Pharm Biotechnol; 2022 May; ():. PubMed ID: 35578839
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal Notice: Dietary Fatty Acids-effects on Cardiovascular Disease.
Khorassani JK; Khorassani SK; Afshari A; Rezayi M; Langari H; Ghayour-Mobarhan M
Mini Rev Med Chem; 2019 Sep; ():. PubMed ID: 31538894
[TBL] [Abstract][Full Text] [Related]
11. WITHDRAWN: The Ascension of Nanosponges as a Drug Delivery Carrier: Preparation, Characterization and Applications.
Tiwari K; Bhattacharya S
Curr Drug Deliv; 2022 Jun; ():. PubMed ID: 35713140
[TBL] [Abstract][Full Text] [Related]
12. Withdrawal Notice: Circulatory Cells as Tumortropic Carrier for Targetability Improvement.
Zou D; Weng Y; Yang P
Curr Drug Deliv; 2020 Nov; ():. PubMed ID: 33234105
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal Notice: Applications of Microbubbes as a Nano-carrier for cancer Theranostics.
Chaudhary A; Setia A; Singh D; Bhattacharya S
Pharm Nanotechnol; 2021 Sep; ():. PubMed ID: 34496738
[TBL] [Abstract][Full Text] [Related]
14. WITHDRAWN: Long-time-released Transdermal Microneedle Delivery System.
Tang X; Qin H; Zhang X; Yang H; Yang J; Chen P; Jin Y; Yang L
Curr Drug Deliv; 2023 Nov; ():. PubMed ID: 38018188
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Rap2A/p-ERK1/2 is Involved in Glioma Proliferation and Migration.
Wang T; Wang J; Liang R; He J; Liao Q; Jiang Y
Curr Mol Med; 2022 Aug; ():. PubMed ID: 35927807
[TBL] [Abstract][Full Text] [Related]
16. WITHDRAWN: Application of Nanoparticles in the Management of Polycystic Ovary Syndrome.
Al-Hetty HRAK; Saleh MM; Jalil AT
Curr Drug Res Rev; 2023 Aug; ():. PubMed ID: 37592786
[TBL] [Abstract][Full Text] [Related]
17. Withdrawal Notice: Antioxidant Effects of Polysaccharides from Traditional Chinese Medicines.
Liu Y; Huang G
Mini Rev Med Chem; 2017 Dec; ():. PubMed ID: 29219054
[TBL] [Abstract][Full Text] [Related]
18. WITHDRAWN: Obesity Paradox and Cardiovascular Diseases.
Ganna I; Anna S
Curr Cardiol Rev; 2022 May; ():. PubMed ID: 35570515
[TBL] [Abstract][Full Text] [Related]
19. WITHDRAWN: Design and Evaluation of Floating Micro-Carriers for Effective Delivery of a Hydrophobic Drug.
Hussain Z; Hongcai L; Ling Z; Nawaz MA; Naz AF; Yong W
Curr Drug Deliv; 2022 May; ():. PubMed ID: 35578878
[TBL] [Abstract][Full Text] [Related]
20. WITHDRAWN: Main Diagnostic Methods for COVID-19: Integrative Review.
de Campos ASM; de Souza GAF; de Jesus RA; Zardeto G; Donadel G; Dalmagro M; de Almeida Canoff JR; Hoscheid J; Alberton O; Boleta-Ceranto DCF; Gonçalves DD; Botelho Lourenço EL; Cogo J
Curr Pharm Des; 2022 May; ():. PubMed ID: 35619252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
